Page 95 - ITPS-7-2
P. 95

INNOSC Theranostics and
            Pharmacological Sciences                                     Sujok therapy for patients with respiratory problems



            “Ethical Lessons Learned During Epidemic Outbreaks” in   relevance of being chronic. Eur Respir J. 2017;50:1701159.
            2021.                                                 doi: 10.1183/13993003.01159-2017
            References                                         14.  Campbell ML, Yarandi H, Dove-Medows E. Oxygen is
                                                                  nonbeneficial for most patients who are near death. J Pain
            1.   Parshall MB, Schwartzstein RM, Adams L, et al. An official   Symptom Manage. 2013;45:517-523.
               American thoracic society statement: Update on the
               mechanisms, assessment, and management of dyspnea. Am      doi: 10.1016/j.jpainsymman.2012.02.012
               J Respir Crit Care Med. 2012;185:435-452.       15.  Delgado-Guay MO, Parsons HA, Li Z, Palmer LJ, Bruera, E.
               doi: 10.1164/rccm.201111-2042ST                    Symptom distress, interventions, and outcomes of intensive
                                                                  care unit cancer patients referred to a palliative care consult
            2.   Pisani L, Hill NS, Pacilli AM, Polastri M, Nava S. Management   team. Cancer. 2009;115:437-445.
               of dyspnea in the terminally ill. Chest. 2018;154:925-934.
                                                                  doi: 10.1002/cncr.24017
               doi: 10.1016/j.chest.2018.04.003
                                                               16.  Nurjannah I. Fourteen days struggling to deal with COVID-
            3.   Budhwar N, Syed Z. Chronic dyspnea: Diagnosis and   19 using Su Jok therapy: A case report.  J Community
               evaluation. Am Fam Physician. 2020;101:542-548.    Empowerment Health. 2022;5:71-76.
            4.   Pratter MR, Curley FJ, Dubois J, Irwin RS. Cause and      doi: 10.22146/jcoemph.66453
               evaluation of chronic dyspnea in a pulmonary disease clinic.
               Arch Intern Med. 1989;149:2277-2282.            17.  Haven B, Sharma S. Oxygen saturation. In:  StatPearls.
                                                                  Treasure Island FL. StatPearls Publishing; 2018.
               doi: 10.1001/archinte.1989.00390100089021
                                                               18.  Hinkelbein J, Koehler H, Genzwuerker HV, Fiedler F.
            5.   Sin DD, Jones RL, Man SF. Obesity is a risk factor for   Artificial acrylic finger nails may alter pulse oximetry
               dyspnea but not for airflow obstruction. Arch Intern Med.   measurement. Resuscitation. 2007;74:75-82.
               2002;162:1477-1481.
                                                               19.  Pesola GR, Ahsan H. Dyspnea as an independent predictor
               doi:10.1001/archinte.162.13.1477                   of mortality. Clin Respir J. 2016;10:142-152.
            6.   Depiazzi J, Everard ML. Dysfunctional breathing and      doi: 10.1111/crj.12191
               reaching  one’s  physiological  limit  as  causes  of  exercise-
               induced dyspnoea. Breathe (Sheff). 2016;12:120-129.  20.  Lee WW, Mayberry K, Crapo R, Jensen RL. The accuracy of
                                                                  pulse oximetry in the emergency department. Am J Emerg
               doi: 10.1183/20734735.007216                       Med. 2000;18:427-431.
            7.   Choi HS, Han SS, Choi HA. Dyspnea and palpitation during      doi: 10.1053/ajem.2000.7330
               pregnancy. Korean J Intern Med. 2001;16:247-249.
                                                               21.  Luks AM, Swenson ER. Pulse oximetry for monitoring
               doi: 10.3904/kjim.2001.16.4.247                    patients with COVID-19 at home. Potential pitfalls and
            8.   Ha D, Ries AL. Characterization of dyspnea in veteran   practical guidance. Ann Am Thrac Soc. 2020;17:1040-1046.
               lung cancer survivors following curative-intent therapy.  J      doi: 10.1513/AnnalsATS.202005-418FR
               Cardiopulm Rehabil Prev. 2020;40:120.
                                                               22.  American Thoracic Society, American College of Chest
               doi: 10.1097/HCR.0000000000000464                  Physicians.  ATS/ACCP Statement on cardiopulmonary
            9.   Mendoza TR, Kehl KL, Bamidele O,  et al. Assessment of   exercise testing. Am J Respir Crit Care Med. 2003;167:211-
               baseline symptom burden in treatment-naïve patients with   217.
               lung cancer: An observational study. Support Care Cancer.   23.  Torp KD, Modi P, Simon LV. In: StatPearls. United States:
               2019;27:3439-3447.                                 StatPearls Publishing; 2021.
            10.  Viniol A, Beidatsch D, Frese T, et al. Studies of the symptom   24.  Sütçü Çiçek H, Gümüs S, Deniz Ö, et al. Effect of nail polish
               dyspnoea: A systematic review. BMC Fam Pract. 2015;16:152.  and henna on oxygen saturation determined by pulse
            11.  Mahler DA. Evaluation of dyspnea in the elderly.  Clin   oximetry in healthy young adult females.  Emerg Med J.
               Geriatr Med. 2017;33:503-521.                      2011;28:783-785.
                                                                  doi:10.1136/emj.2010.096073
            12.  Ho S, O’Mahony MS, Steward JA, Breay P, Buchalter M, Burr
               ML. Dyspnoea and quality of life in older people at home.   25.  Bickler PE, Feiner JR, Severinghaus JW. Effects of skin
               Age Ageing. 2001;30:155-159.                       pigmentation on pulse oximeter accuracy at low saturation.
               doi: 10.1016/S0749-0690(02)00050-2                 Anesthesiology. 2005;102:715-719.
                                                                  doi: 10.1097/00000542-200504000-00004
            13.  Morélot-Panzini C, Adler D, Aguilaniu B, et al. Breathlessness
               despite optimal pathophysiological treatment: On the   26.  Feiner JR, Severinghaus JW, Bickler PE. Dark skin decreases


            Volume 7 Issue 2 (2024)                         9                                doi: 10.36922/itps.1418
   90   91   92   93   94   95   96   97   98   99   100